NIT
AMRX icon

NumerixS Investment Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History

NumerixS Investment Technologies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,135
Closed -$34K – 980
2019
Q4 		$34K Buy
+7,135
New +$24.8K 0.01% 878
2019
Q2 		– Sell
-3,052
Closed -$42K – 1044
2019
Q1 		$42K Buy
3,052
+1,045
+52% +$13.8K 0.01% 1009
2018
Q4 		$28K Sell
2,007
-22,993
-92% -$414K 0.01% 871
2018
Q3 		$547K Sell
25,000
-12,100
-33% -$255K 0.1% 274
2018
Q2 		$607K Buy
+37,100
New +$651K 0.14% 208

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

NumerixS Investment Technologies's AMRX Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Amneal Pharmaceuticals (AMRX) in Q1 2020, closing a stake of 7,135 shares — an estimated $34K sold.

NumerixS Investment Technologies first reported a position in AMRX in Q2 2018 and held it in 5 quarters. The position peaked at $607K in Q2 2018. 127 funds tracked by Wall St. Rank hold AMRX as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Amneal Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 7,135 Amneal Pharmaceuticals shares in Q1 2020, an estimated $34K.
  • NumerixS Investment Technologies first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • NumerixS Investment Technologies's Amneal Pharmaceuticals position peaked at $607K in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.